| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |